Advaccine Biotech
Latest round
- Series C
Last raised
- Jan 2025
Total raised
- $29M
Investors
- 11
About Advaccine Biotech
Based in Suzhou, China, and established in 2009, Advaccine Biotech is a biotechnology company that focuses on vaccine production. The company has merged with SA Biotech (Suzhou) Pte Ltd and established a large-scale vaccine production system in Suzhou. In December 2020, the initiation of phase II clinical trial of pGX9501 was started. Xian Zhu, the founder and president of the company, has served as Executive Vice President, Chief Scientific Officer, and Chief Biologics Officer for multinational companies such as Fidelity Animal Health, Pfizer Animal Health, etc. Advaccine Biotech engages in the development and production of new preventive vaccines and therapeutic vaccines, which can prevent and treat diseases caused by excessive immune responses. The vaccine production of the company includes innovative vaccine technologies such as DNA nucleic acid vaccines, recombinant protein vaccines, and new vaccine adjuvants. It is developing COVID-19 DNA vaccine, new respiratory syncytial virus (RSV) pneumonia vaccine, hepatitis B therapeutic vaccine, etc. The company generates revenue by developing pet vaccines.
Who invested in Advaccine Biotech
11 investors across 4 rounds
See all investors in Advaccine Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Advaccine Biotech
Who invested in Advaccine Biotech?
Advaccine Biotech has 11 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Advaccine Biotech raised?
Advaccine Biotech has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Advaccine Biotech last raise money?
Advaccine Biotech's most recent round on record is a Series C, in Jan 2025.
What does Advaccine Biotech do?
Based in Suzhou, China, and established in 2009, Advaccine Biotech is a biotechnology company that focuses on vaccine production.
Where is Advaccine Biotech headquartered?
Advaccine Biotech is headquartered in Suzhou, China.
Which VCs invest in companies like Advaccine Biotech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Advaccine Biotech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Advaccine Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.